TCRT · Alaunos Therapeutics, Inc. · Fails to Deliver
$1.66
+0.07 (+4.40%)
At close · Nov 20
Return incl. dividend (before tax)
Q1 2023 earnings call transcript
Going-concern doubt
— cleared Nov 16, 2026
The latest filing states the doubt was alleviated.
“These conditions initially raised substantial doubt about the Company’s ability to continue as a going concern. Accordingly, management has concluded that the substantial doubt previously identified about our ability to continue as a going concern has been alleviated.”View the 10-Q filed Nov 16, 2026
Market Cap
$6.99M
Shares
4.21M
Volume · Nov 20
77.56K
Avg daily vol (3M)
7.44M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-10-30 | 4,060 | $1.89 | $7,673 |
| 2026-10-29 | 23,037 | $2.13 | $49,069 |
| 2026-10-28 | 3,911 | $2.06 | $8,057 |
| 2026-10-27 | 2,997 | $2.13 | $6,384 |
| 2026-10-26 | 21,459 | $2.28 | $48,927 |
| 2026-10-23 | 43,064 | $3.04 | $130,915 |
| 2026-10-22 | 86,130 | $3.08 | $265,280 |
| 2026-10-21 | 234,289 | $2.97 | $695,838 |
| 2026-10-20 | 398,494 | $3.13 | $1,247,286 |
| 2026-10-19 | 319,015 | $2.63 | $839,009 |
| 2026-10-16 | 642,478 | $2.18 | $1,400,602 |
| 2026-10-15 | 450,392 | $2.07 | $932,311 |
| 2026-10-14 | 523,112 | $3.03 | $1,585,029 |
| 2026-10-13 | 105,999 | $1.05 | $111,299 |
| 2026-10-09 | 13,700 | $0.78 | $10,686 |
| 2026-10-08 | 5,729 | $0.85 | $4,870 |
| 2026-10-05 | 108 | $0.82 | $89 |
| 2026-10-01 | 973 | $0.88 | $856 |
| 2026-09-25 | 10,069 | $1.13 | $11,378 |
| 2026-09-24 | 1,854 | $1.15 | $2,132 |
| 2026-09-23 | 230 | $1.27 | $292 |
| 2026-09-22 | 749,239 | $1.26 | $944,041 |
| 2026-09-21 | 840,991 | $1.20 | $1,009,189 |
| 2026-09-18 | 208,418 | $1.60 | $333,469 |
| 2026-09-17 | 2,239 | $1.28 | $2,866 |
Showing 1–25 of 25 settlements
Key facts
CIK
1107421
CUSIP
98973P309
13F (30d)
39 filings
30 filers
Visit website
Investor relations